tag:blogger.com,1999:blog-6821948329541212415.post3082232290521489141..comments2024-02-24T03:48:31.640-05:00Comments on NIHilist's Immunology: How to identify tumor-associated immunogenic peptides for immunotherapy? David Usharaulihttp://www.blogger.com/profile/02668672470276307921noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-6821948329541212415.post-89215347984341138652016-05-11T11:54:33.777-04:002016-05-11T11:54:33.777-04:00Thanks for commenting. Sure, peptide elution is mo...Thanks for commenting. Sure, peptide elution is more definitive. However, for large scale application of personalized tumor immune landscape in clinical setting, reliable algorithms would help a lot (at least for cost reduction and affordability).<br /><br />David<br /> David Usharaulihttps://www.blogger.com/profile/02668672470276307921noreply@blogger.comtag:blogger.com,1999:blog-6821948329541212415.post-52755960910685729282016-05-11T11:22:10.124-04:002016-05-11T11:22:10.124-04:00Hi David, I imagine that immunizing with algorithm...Hi David, I imagine that immunizing with algorithm predicted peptides is a bit of fishing, whereas eluted MHC1 is relatively more definitive because they are there. If resource allows, algorithm peptides would definitely be interesting. Anonymoushttps://www.blogger.com/profile/14113116451104993697noreply@blogger.com